| Clubbed triazoles: a novel approach to antitubercular drugs M Shiradkar, GVS Kumar, V Dasari, S Tatikonda, KC Akula, R Shah European journal of medicinal chemistry 42 (6), 807-816, 2007 | 187 | 2007 |
| A highly efficient catalyst for oxime ligation and hydrazone–oxime exchange suitable for bioconjugation M Rashidian, MM Mahmoodi, R Shah, JK Dozier, CR Wagner, ... Bioconjugate chemistry 24 (3), 333-342, 2013 | 148 | 2013 |
| HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia J Garzón, R Herrero-Labrador, M Rodríguez-Muñoz, R Shah, ... Neuropharmacology 89, 412-423, 2015 | 47 | 2015 |
| Caught before Released: Structural Mapping of the Reaction Trajectory for the Sofosbuvir Activating Enzyme, Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) R Shah, KM Maize, X Zhou, BC Finzel, CR Wagner Biochemistry 56 (28), 3559-3570, 2017 | 25 | 2017 |
| Anchimerically Activatable Antiviral ProTides A Okon, MR Matos de Souza, R Shah, R Amorim, LJ Da Costa, ... ACS Medicinal Chemistry Letters 8 (9), 958-962, 2017 | 22 | 2017 |
| In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures R Shah, J Petersburg, AC Gangar, A Fegan, CR Wagner, ... Molecular pharmaceutics 13 (7), 2193-2203, 2016 | 22 | 2016 |
| A Crystal Structure Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides KM Maize, R Shah, A Strom, S Kumarapperuma, A Zhou, CR Wagner, ... Molecular pharmaceutics 14 (11), 3987-3997, 2017 | 21 | 2017 |
| Design, Synthesis, and Characterization of Sulfamide and Sulfamate Nucleotidomimetic Inhibitors of hHint1 R Shah, A Strom, A Zhou, KM Maize, BC Finzel, CR Wagner ACS Medicinal Chemistry Letters 7 (8), 780-784, 2016 | 14 | 2016 |
| Structure and Functional Characterization of Human Histidine Triad Nucleotide Binding Protein 1 Mutations Associated with Inherited Axonal Neuropathy with Neuromyotonia RM Shah, KM Maize, HT West, AM Strom, BC Finzel, CR Wagner Journal of Molecular Biology, 2018 | 13 | 2018 |
| Inhibition by divalent metal ions of human histidine triad nucleotide binding protein1 (hHint1), a regulator of opioid analgesia and neuropathic pain R Shah, TF Chou, KM Maize, A Strom, BC Finzel, CR Wagner Biochemical and biophysical research communications 491 (3), 760-766, 2017 | 8 | 2017 |
| Switch-on fluorescent/FRET probes to study human histidine triad nucleotide binding protein 1 (hHint1), a novel target for opioid tolerance and neuropathic pain R Shah, A Zhou, CR Wagner Organic & biomolecular chemistry 15 (48), 10230-10237, 2017 | 8 | 2017 |
| Using Molecular Docking to Develop Inhibitors of DPP-IV Enzyme MA Hendawy, AS Mehanna, RM Shah FASEB JOURNAL 32 (1), 2018 | | 2018 |
| SULFAMIDE AND SULFAMATE INHIBITORS OF hHint1 CR Wagner, R Shah US Patent App. 15/673,297, 2018 | | 2018 |
| Design, Modeling, Synthesis and in Vitro evaluation of new DPP-IV inhibitors Rachit M. Shah, Moataz A. Hendawy and Ahmed S. Mehanna Journal of Medicinal Chemistry and Toxicology 3 (1), 100-110, 2018 | | 2018 |
| A New Target for Pain: Development of Tools to Study Human Histidine Triad Nucleotide Binding proteins R Shah | | 2017 |
| Structural and functional characterization of histidine triad nucleotide binding protein 1 mutants associated with inherited peripheral neuropathy R Shah, K Maize, B Finzel, C Wagner ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | | 2015 |
| Design, Synthesis and In-vitro Testing of Beta-amino Acid Derivatives as Potential Dipeptidyl Peptidase-IV Inhibitors RM Shah Massachusetts College of Pharmacy and Health Sciences, 2011 | | 2011 |
